Anglo American plc
Anglo American plc (NGLOY) Financial Performance & Income Statement Overview
Review Anglo American plc (NGLOY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Anglo American plc (NGLOY) Income Statement & Financial Overview
Explore comprehensive income reports for Anglo American plc NGLOY, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $12.83B | $14.46B | $14.83B | $15.71B |
| Cost of Revenue | -$5.82B | $5.82B | $11.81B | $12.28B |
| Gross Profit | $18.64B | $8.65B | $3.02B | $3.43B |
| Gross Profit Ratio | $1.45 | $0.60 | $0.20 | $0.22 |
| R&D Expenses | -$54.00M | $54.00M | $0.00 | $61.00M |
| SG&A Expenses | -$3.32B | $3.32B | $115.00M | $3.30B |
| Operating Expenses | $20.39B | $7.12B | $2.29B | $5.53B |
| Total Costs & Expenses | $14.58B | $12.94B | $11.81B | $12.28B |
| Interest Income | $25.00M | $401.00M | $200.39M | $198.00M |
| Interest Expense | $1.17B | $0.00 | $752.97M | $625.00M |
| Depreciation & Amortization | $1.61B | $1.46B | $1.50B | $1.26B |
| EBITDA | -$1.49B | $4.81B | $2.49B | $4.67B |
| EBITDA Ratio | -$0.12 | $0.33 | $0.30 | $0.30 |
| Operating Income | -$3.58B | $3.35B | $3.02B | $3.43B |
| Operating Income Ratio | -$0.28 | $0.23 | $0.20 | $0.22 |
| Other Income/Expenses (Net) | $1.53B | -$2.23B | -$2.57B | -$246.00M |
| Income Before Tax | -$2.05B | $1.12B | $450.39M | $2.76B |
| Income Before Tax Ratio | -$0.16 | $0.08 | $0.03 | $0.18 |
| Income Tax Expense | $543.00M | $1.32B | $1.07B | $1.17B |
| Net Income | -$2.40B | -$672.00M | -$971.22M | $1.26B |
| Net Income Ratio | -$0.19 | -$0.05 | -$0.07 | $0.08 |
| EPS | -$1.98 | -$0.55 | -$0.40 | $0.52 |
| Diluted EPS | -$1.98 | -$0.55 | -$0.40 | $0.52 |
| Weighted Avg Shares Outstanding | $1.21B | $1.21B | $2.42B | $2.43B |
| Weighted Avg Shares Outstanding (Diluted) | $1.21B | $1.21B | $2.42B | $2.44B |
Over the past four quarters, Anglo American plc demonstrated steady revenue growth, increasing from $15.71B in Q2 2023 to $12.83B in Q4 2024. Operating income reached -$3.58B in Q4 2024, maintaining a consistent -28% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.49B, reflecting operational efficiency. Net income dropped to -$2.40B, with EPS at -$1.98. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan